Investigations with specific PET ligands that bind to specific neuro-recept
ors give information on abnormalities of neurotransmission involved in the
pathophysiology of the epilepsies. Data need to be interpreted in the light
of optimal structural imaging. Objective voxel-based and region-based anal
yses, with correction of partial volume effect, are complementary. Central
benzodiazepine (cBZR) and opioid receptors have been studied most. Reduced
cBZR binding is commonly seen at an epileptic focus, in a more restricted d
istribution than an area of hypometabolism, and sometimes also in projectio
n areas. In contrast to acquired lesions causing partial seizures, focal in
creases in cBZR binding have been demonstrated in malformations of cortical
development and also in areas of brain that appear normal on MAI, indicati
ng the widespread nature of the abnormalities. Focal abnormalities of cBZR
are also commonly found in patients with partial seizures and normal MRI. I
t is not yet clear how useful these data will prove to be in presurgical ev
aluation. Mu- and delta-opioid receptors have been found to be increased in
temporal neocortex overlying mesial temporal epileptic foci, but with diff
erent patterns of increase. Dynamic studies of the binding of 11C-diprenorp
hine to opioid receptors are possible using PET, and have implied the relea
se of cerebral endogenous opioids at the time of serial absences and reflex
seizures induced by reading.
Other tracers, that have been applied less widely, label the enzyme monoami
ne oxidase type B and peripheral benzodiazepine and histamine H1 receptors.